Clinical Trial Update: Degarelix Neo-Adjuvant Radical Prostatectomy Trial [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating degarelix as neoadjuvant therapy before radical prostatectomy for prostate cancer, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED